| NCT ID | NCT00064870 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Alzheimer Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2002-06 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2002-06 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Eligibility Criteria
Inclusion Criteria: * Two living family members diagnosed with AD or other dementia with any age of onset * Biological samples available * Fresh blood, or * Immortalized lymphoblastic cell lines, or * 3-5 grams of frozen cerebral cortex; fixed samples are not accepted Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members. Exclusion Criteria: * Does not meet inclusion criteria * Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection
Contact & Investigator
Tatiana M. Foroud, PhD
PRINCIPAL INVESTIGATOR
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University
Frequently Asked Questions
Who can join the NCT00064870 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00064870 currently recruiting?
Yes, NCT00064870 is actively recruiting participants. Contact the research team at alzstudy@iu.edu for enrollment information.
Where is the NCT00064870 trial being conducted?
This trial is being conducted at Nationwide, United States.
Who is sponsoring the NCT00064870 clinical trial?
NCT00064870 is sponsored by Indiana University. The principal investigator is Tatiana M. Foroud, PhD at National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.